Panel weighs safety, effectiveness of Merck’s COVID-19 pill
By MATTHEW PERRONE AP Health Writer WASHINGTON (AP) — U.S. health advisers are reviewing Merck’s closely watched COVID-19 pill, which could become the first easy-to-use drug for American patients. The Food and Drug Administration asked its outside experts Tuesday whether the agency should authorize the pill. They are weighing new data that the pill is
Continue Reading